A new Risk Evaluation and Mitigation Strategy will give physicians and other prescribers the tools to reduce the risk of prescription drug abuse while maintaining timely access to pain management care, according to a report by the U.S. News & World Report.
REMS is part of a larger federal crackdown on prescription drug abuse, announced earlier this week by the Obama administration. The program will require prescription drug manufacturers to use one central system for providing education materials to physicians and patients. The educational material will cover extended-release medications and may eventually be expanded to include immediate-release drugs, according to the news report.
In addition, the Obama administration is seeking to pass legislation that would require physicians to undergo training before being allowed to prescribe controlled substances such as Oxycontin.
Read the news report about REMS.
Read other coverage about pain management:
- Obama Administration Wants Tighter Control on Prescriptions
- New Nerve Block Technology Shows Promise in Feasibility Studies
REMS is part of a larger federal crackdown on prescription drug abuse, announced earlier this week by the Obama administration. The program will require prescription drug manufacturers to use one central system for providing education materials to physicians and patients. The educational material will cover extended-release medications and may eventually be expanded to include immediate-release drugs, according to the news report.
In addition, the Obama administration is seeking to pass legislation that would require physicians to undergo training before being allowed to prescribe controlled substances such as Oxycontin.
Read the news report about REMS.
Read other coverage about pain management:
- Obama Administration Wants Tighter Control on Prescriptions
- New Nerve Block Technology Shows Promise in Feasibility Studies